CUSIP: 00507W107
Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
8,833,329
-
Share change
-
+589
-
Total reported value
-
$4,226,000
-
Price per share
-
$0.48
-
Number of holders
-
40
-
Value change
-
+$25,240
-
Number of buys
-
10
-
Number of sells
-
14
Quarterly Holders Quick Answers
What is CUSIP 00507W107?
CUSIP 00507W107 identifies ATNM - ACTINIUM PHARMACEUTICALS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q2 2019
-
Previous quarter:
Q4 2018
Recent filing periods for CUSIP 00507W107:
Institutional Holders of ACTINIUM PHARMACEUTICALS INC - COM (ATNM) as of Q1 2019
As of 31 Mar 2019,
ACTINIUM PHARMACEUTICALS INC - COM (ATNM) was held by
40 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,833,329 shares.
The largest 10 holders included
VANGUARD GROUP INC, PNC Financial Services Group, Inc., BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, Sio Capital Management, LLC, NORTHERN TRUST CORP, OPPENHEIMER & CO INC, Cetera Advisor Networks LLC, DLD Asset Management, LP, and RENAISSANCE TECHNOLOGIES LLC.
This page lists
40
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.